Definitive Healthcare (NASDAQ:DH) Stock Price Up 4.7% - Should You Buy?

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report)'s stock price was up 4.7% during mid-day trading on Tuesday . The company traded as high as $3.89 and last traded at $3.94. Approximately 172,040 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 787,582 shares. The stock had previously closed at $3.76.

Analysts Set New Price Targets

A number of research firms have commented on DH. Wall Street Zen downgraded shares of Definitive Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, May 31st. The Goldman Sachs Group increased their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. BTIG Research lowered Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Barclays reduced their target price on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a report on Monday, March 3rd. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $5.10.

Definitive Healthcare Stock Performance

The company has a market capitalization of $564.83 million, a price-to-earnings ratio of -0.87, a P/E/G ratio of 6.61 and a beta of 1.58. The stock has a 50 day simple moving average of $3.17 and a 200 day simple moving average of $3.69. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The business had revenue of $59.19 million during the quarter, compared to analyst estimates of $56.20 million. During the same quarter in the previous year, the firm posted $0.08 EPS. The business's revenue for the quarter was down 6.8% compared to the same quarter last year. As a group, analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Definitive Healthcare

Hedge funds have recently made changes to their positions in the business. Bayesian Capital Management LP acquired a new stake in Definitive Healthcare in the fourth quarter worth about $41,000. Ieq Capital LLC acquired a new stake in shares of Definitive Healthcare in the 4th quarter worth approximately $51,000. KLP Kapitalforvaltning AS bought a new position in shares of Definitive Healthcare in the fourth quarter valued at approximately $54,000. Two Sigma Securities LLC acquired a new position in shares of Definitive Healthcare during the fourth quarter valued at approximately $56,000. Finally, ProShare Advisors LLC raised its holdings in Definitive Healthcare by 49.1% during the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after purchasing an additional 4,943 shares in the last quarter. Institutional investors own 98.67% of the company's stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.